OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS

Mergers & Acquisitions

Mergers & Acquisitions Summary

Each week, Viridian publishes insights and analysis on completed M&A transactions in the prior week. Our analysis includes:

    • M&A Market Commentary
    • Public and Private Companies
    • Buyers & Sellers
    • YTD M&A Analysis
    • M&A by Industry Sector
    • Deal Structure and Valuation Analysis
    • Pending Deal Risk Arb Analysis
    • Valuation Gap Analysis

Quick Links

Transaction Activities

Week ended 03/24/2023

  • Three M&A transactions closed this week for non-disclosed value compared to one transaction in the prior year.

 

YTD Activities

  • Thirty-two transactions totaling $741.81M have closed YTD, compared to fifty-seven transactions for $2,031.16M last year.
  • The 2023 YTD average transaction size of $23.18M is the lowest in recent years.

Pending Risk Deal Arb Analysis

    • The Cresco/Columbia deal spread narrowed by 330bp to 61.9% on 3/24/23,  an impressive performance given the general feel of the cannabis market. Still, a 61.9% arb spread screams skepticism that the agreement will survive as presently structured because that return over a four-month horizon seems too good to be true. If you think this deal will close, as does one noted sell-side analyst we respect, then why wouldn’t you try to establish the arb position of being long Columbia and short Cresco?

   

Valuation Gap Analysis

  • The valuation gap widened to 1.94 on 3/24/23 but remained close to the lowest since we began tracking this measure. The valuation gap is the difference between the EV/NTM EBITDA multiple for the largest MSOs and the multiple for the less than $300M market cap group, which are their primary targets.
  • This measure has been a significant driver of M&A activity since a larger gap creates an opportunity for more accretive transactions. The gap tends to increase in improving markets while declining in retreating markets to the greater trading liquidity of the larger companies. We believe the current gap is understated by the massive illiquidity of cannabis stocks which may not be accurate indicators of the prices at which the entire companies would trade.

Please login to your account to view data charts.